What is the Ownership and Shareholding Structure of H S Pathology?
In 2023, H S Pathology had a promoter holding of 28.32% and a public holding of 71.68%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.










Company Details
+91-XXXXXXXXXX